Department of Pediatrics

October 1, 2021

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

Meg Rush, MD, MMHC, testifying before Congress on Sept. 22.
September 27, 2021

Rush testifies before Congress on pandemic’s impact on children

Vanderbilt’s Meg Rush, MD, MMHC, spoke to several members of Congress recently and painted a vivid picture of the toll the virus has taken on children in Tennessee and at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

September 22, 2021

Kannankeril named inaugural holder of the Richard B. Johnston Jr., MD, Chair in Pediatric Research

Prince Kannankeril, MD, MSCI, has been appointed inaugural holder of the Richard B. Johnston Jr. MD, Chair in Pediatric Research at Vanderbilt University Medical Center.

September 17, 2021

Grant creates center for maternal, pediatric precision therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.

September 16, 2021

‘Pre-conditioning’ restores immune tolerance

A treatment targeting T-cell metabolism could reinvigorate immune tolerance mechanisms to combat autoimmune disease and transplant rejection, Vanderbilt researchers discovered.

September 15, 2021

Older age, chronic co-morbidities associated with more severe COVID disease in children

Vanderbilt research found that multiple factors are associated with the severity of COVID-19 disease in children, including older age and chronic co-morbidities such as obesity, diabetes and neurologic conditions.